Accessory genes of the Paramyxoviridae, a large family of nonsegmented negative-strand RNA viruses, as a focus of active investigation by reverse genetics

Current Topics in Microbiology and Immunology

Volumn 283, Issue , 2004, Pages 197-248

  Nagai, Y ^a   Kato, A ^b  

^a TOYAMA INSTITUTE OF HEALTH   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; VIRUS PROTEIN;

ACCESSORY GENE; GENE DISRUPTION; GENE ISOLATION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HUMAN; NONHUMAN; NUCLEOTIDE SEQUENCE; PARAMYXOVIRUS; PHENOTYPE; PLASMID; PRIORITY JOURNAL; PROTEIN FUNCTION; REVERSE GENETICS; REVIEW; RNA TRANSLATION; RNA VIRUS; VIRAL GENETICS; VIRUS GENE; VIRUS GENOME; VIRUS INFECTION; VIRUS INFECTIVITY; VIRUS MUTANT; VIRUS PATHOGENESIS; VIRUS REPLICATION;

ANIMALIA; PARAMYXOVIRIDAE; RNA VIRUSES;

EID: 2442700397     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-662-06099-5_6     Document Type: Review

References (164)

1. Aaronson DS, and Horvath CM (2002) A road map for those who don't know JAK-STAT. Science 296, 1653-1655
2. Andrejeva J, Poole E, Young DF, Goodbourn S, and Randall RE (2002a) The p127 subunit (DDB1) of the UV-DNA damage repair binding protein is essential for the targeted degradation of STAT1 by the V protein of the paramyxovirus simian virus 5. J. Virol. 76, 11379-11386
3. Andrejeva J, Young DF, Goobourn S, and Randall RE (2002b) Degradation of STAT1 and STAT2 by the V proteins of simian virus 5 and human parainfluenza virus type 2, respectively: consequences for virus replication in the presence of alpha/beta and gamma interferons. J. Virol. 76, 2159-2167
4. Baron MD, and Barrett T (2000) Rindsepest viruses lacking the C and V proteins show specific defects in growth and transcription of viral RNAs. J. Virol. 74, 2603-2611
5. Basler CF, Wang X, Mühlberger E, Vulchkov V, Paragas J, Klenk HD, Garcia-Sastre A, and Palese P (2000) The Ebola virus VP35 protein functions as a type 1 IFN antagonist. Proc. Natl. Acad. Sci. USA 97, 12289-12294
6. Bermingham A, and Collins PL (1999) The M2-2 protein of human respiratory syncytial virus is a regulatory factor involved in the balance between RNA replication and transcription. Proc. Natl. Acad. Sci. USA 96, 11259-11264
7. Biron CA, and Sen GC (2001) Interferons and other cytokines. In Fields Virology 4th ed. pp. 321-351. Lippincott Williams & Wilkins, Philadelphia
8. Bitzer M, Prinz F, Bauer M, Spiegel M, Neubert WJ, Gregor M, Schulze-Osthoff K, and Lauer U (1999) Sendai virus infection induces apoptosis through activation of caspase-8 (FLICE) and caspase-3 (CPP32). J. Virol. 73, 702-708
9. Bossert B, and Conzelmann KK (2002) Respiratory syncytial virus (RSV) nonstructural (NS) proteins as host range determinants: a chimeric bovine RSV with NS genes from human RSV is attenuated in interferon-competent bovine cells. J. Virol. 76, 4287-4293
10. Buchholz UJ, Finke S, and Conzelmann, KL (1999) Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in acts as a functional BRSV genome promoter. J. Virol. 73, 251-259
11. Burkreyev A, Whitehead SS, Murphy BR, and Collins PL (1997) Recombinant respiratory syncytial virus from which the SH gene has been deleted grows efficiently in cell culture and exhibits site specific attenuation in the respiratory tract of the mouse. J. Vitrol. 71, 8973-8982
12. Cadd T, Garcin D, Tapparel C, Itoh M, Homma M, Roux L, Curren J, and Kolakofsky D (1996) The Sendai paramyxovirus accessory C proteins inhibit viral genome amplification in a promoter-specific fashion. J. Virol. 70, 5067-5074
13. Cathomen T, Mrkic B, Spehner D, Drillien R, Naef R, Pavlovic J, Aguzzi A, Billeter MA, and Cattaneo R (1998) A matrix-less measles virus is infectious and elicits extensive cell fusion: consequences for propagation in the brain. EMBO J. 17, 3899-3908
14. Cattaneo R, Kaelin K, Baczko K, and Billeter MA (1989) Measles virus editing provides an additional cysteine-rich protein. Cell 56, 759-764
15. Chanock RM, Miuphy BR, and Collins PL (2001) Parainfluenza viruses. In Fields Virology 4th ed. pp. 1341-1379. Lippincott Williams & Wilkins, Philadelphia
16. Chatziandreu N, Young D, Andrejeva J, Goodbourn S, and Randall RE (2002) Differences in interferon sensitivity and biological properties of two related isolates of simian virus 5: a model for viral persistence. Virology 293, 234-242
17. Chazal N, and Gerlier D. (2003). Virus entry, assembly, budding, and membrane rafts. Microbiol Mol Biol Rev. 67, 226-237
18. Choppin PW (1964) Multiplication of a myxovirus (SV5) with minimal cytopathic effects and without interference. Virology 23, 224-233
19. Choppin PW, and Compans RW (1975) Reproduction of paramyxoviruses. In: H Fraenkel-Conrat, and RR Wagner, eds. Comprehensive Virology vol. 4, pp. 95-179 Plenum Press, New York
20. Collins PL, Hill MG., Camargo E, Grosfeld H, Chanock RM, and Murphy BR (1995) Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5′ proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development. Proc. Natl. Acad. Sci. USA 92, 11563-11567
21. Collins PL, Chanock RM, and Murphy, BR (2001) Respiratory syncytial virus. In Fields Virology 4th ed. pp. 1443-1485. Lippincott Williams & Wilkins, Philadelphia
22. Crooze E, Usacheva A, Asarnow D, Minshall RD, Perez HD, and Colamonici O (2000) Receptor for activated C-kinase (RACK-1), a WD motif containing protein, specifically associates with the human type I IFN receptor. J. Immunol. 165, 5127-5132
23. Curran J, and Kolakofsky D (1987) Identification of an additional Sendai virus non-structural protein encoded by the P/C mRNA. J. Gen. Virol. 68, 2515-2519
24. Curran J, and Kolakofsky D (1988) Ribosomal initiation from an ACG codon in the Sendai virus P/C mRNA. EMBO J. 7, 245-251
25. Curran J, and Kolakofsky D (1989) Scanning independent ribosomal initiation of the Sendai virus Y proteins in vitro and in vivo. EMBO J. 8, 521-526
26. Curran J, Boeck R, and Kolakofsky D (1991) The Sendai virus P gene expresses both an essential protein and an inhibitor of RNA synthesis by shuffling modules via mRNA editing. EMBO J. 10, 3079-3085
27. Curran J, Marq JB, and Kolakofsky D (1992) The Sendai virus nonstructural C proteins specifically inhibit viral mRNA synthesis. Virology 189, 647-656
28. Delenda C, Hausmann S, Garcin D, and Kolakofsky D (1997) Normal cellular replication of Sendai virus without the trans-frame, nonstructural V protein. Virology 228, 55-62
29. Delenda C, Taylor G, Hausmann S, Garcin D, and Kolakofsky D (1998) Sendai viruses with altered P, V, and W protein expression. Virology 242, 327-337
30. Didcock L, Young DF, Goodbourn S, and Randall RE (1999a) Sendai virus and simian virus 5 block activation of interferon-responsive genes: importance for viral pathogenesis. J. Virol. 73, 3125-3133
31. Didcock L, Young DF, Goodbourn S, and Randall RE (1999b) The V protein of simian virus 5 inhibits interferon signaling by targeting STAT1 for proteasome-mediated degradation. J. Virol. 73, 9928-9933
32. Durbin AP, McAuliffe JM, Collins PL, and Murphy BR (1999) Mutations in the C, D, and V open reading frames of human parainfluenza virus type 3 attenuate replication in rodents and primates. Virology 261, 319-330
33. Escoffier C, Manié S, Vincent S, Muller CP, Billeter M, and Gerlier D (1999) Non-structural C protein is required for efficient measles virus replication in human peripheral blood cells. J. Virol. 73, 1695-1698
34. Fearns R, Collins PL (1999) Role of the M2-1 transcription anti-termination protein of respiratory syncytial virus in sequential transcription. J. Virol. 73, 5852-5864
35. Fujii Y, Sakaguchi T, Kiyotani K, Huang C, Fukuhara N, Egi Y. and Yoshida T (2002) Involvement of the leader sequence in Sendai virus pathogenesis revealed by recovery of pathogenic field isolate from cDNA. J. Virol. 76, 8540-8547
36. Fukuhara N, Huang C, Kiyotani K, Yoshida T, and Sakaguchi T (2002) Mutational analysis of the Sendai virus V protein: importance of the conserved residues for Zn binding, virus pathogenesis and efficient RNA editing. Virology 299, 172-178
37. Garcia-Barreno B, Delgado T, and Melero JA (1996) Identification of protein regions involved in the interaction of human respiratory syncytial virus phosphoprotein and nucleoprotein: Significance for nucleocapsid assembly and formation of cytoplasmic inclusions. J. Virol. 70, 801-808
38. Garcin D, Pelet T, Calain P, Roux L, Curran J, and Kolakofsky D (1995) A highly recombinogenic system for the recovery of infectious Sendai paramyxovirus from cDNA: generation of a novel copy-back nondefective interfering virus. EMBO J. 14, 6087-6094
39. Garcin D, Latore P, and Kolakofsky D (1999) Sendai virus C proteins counteract the interferon-mediated induction of an antiviral state. J. Virol. 73, 6559-6565
40. Garcin D, Curran J, and Korakofsky D (2000) Sendai virus C proteins must interact directly with cellular components to interfere with interferon action. J. Virol. 74, 8823-8830
41. Garcin D, Curran JM, Itoh D, and Kolakofsky (2001) Longer and shorter forms of Sendai virus C proteins play different roles in modulating the cellular antiviral response. J. Virol. 75, 6800-6807
42. Garcin D, Marq JB, Stahle L, Le Mercier P. and Kolakofsky D (2002) All four Sendai Virus C proteins bind STAT1, but only the larger forms also induce its monoubiquitination and degradation. Virology 295, 256-265
43. Garcin D, Marq JB, Goodbourn S, and Kolakofsky D (2003) The amino-terminal extensions of the longer Sendai virus C proteins modulate pY701-Stat1 and bulk Stat1 levels independently of interferon signaling. J. Virol. 77, 2321-2329
44. Goodbourn S, Didcock L, and Randall RE (2000) Interferons: Cell signaling, immune modulation, antiviral response and virus countermeasures. J. Gen. Virol. 81, 2341-2364
45. Gotoh B, Takeuchi K, Komatsu T, Yokoo, J, Kimura Y, Kato A, Kurotani, and Nagai Y (1999) Knockout of the Sendai virus C genes eliminates the viral ability to prevent the interferon- α/β mediated responses. FEBS Lett. 459, 205-210
46. Gotoh B, Komatsu T, Takeuchi K, and Yokoo J (2001) Paramyxovirus accessory proteins as interferon antagonists. Microbiol Immunol 45, 787-800
47. Gotoh B, Komatsu T, Takeuchi K, and Yokoo J (2002) Paramyxovirus strategies for evading the interferon response. Rev. Med. Virol. 12, 337-357
48. Gotoh B, Takeuchi K, Komatsu T, and Yokoo J (2003) The STAT2 activation process is a crucial target of Sendai virus C protein for the blockade of alpha interferon signaling. J. Virol. 77, 3360-3370
49. Grogan CC, and Moyer SA (2001) Sendai virus wild-type and mutant C protein show a direct correlation between L polymerase binding and inhibition of viral RNA synthesis. Virology 288, 96-108
50. Hamaguchi M, Yoshida T, Nishikawa K, Naruse H, and Nagai Y (1983) Transcriptive complex of Newcastle disease virus. I. Both L and P proteins are required to constitute an active complex. Virology 128, 105-117
51. Harcourt BH, Tamin A, Ksiazek TG, Rollin PE, Anderson LJ, Bellini WJ, and Rota PA (2000) Molecular characterization of Nipah virus, a newly emergent paramyxovirus. Virology 271, 334-349
52. Hardy RW, and Wertz GW (1998) The product of the respiratory syncytial virus M2 gene ORF1 enhances readthrough of intergenic junctions during viral transcription. J. Virol. 72, 520-526
53. Hardy RW, Harman SB, and Wertz GW (1999) Diverse gene junctions of respiratory syncytial virus modulate the efficiency of transcription termination and respond differently to M2-mediated antitermination. J. Virol. 73, 170-176
54. Hasan Mk, Kato A, Muranaka, M, Yamaguchi R, Sakai Y, Hatano I, Tashiro M. and Nagai Y (2000) Versatility of the accessory C proteins of Sendai virus. Contribution to virus assembly as an additional role. J. Virol. 74, 5619-5628
55. He B, Leser GP, Paterson RG, and Lamb RA (1998) The paramyxovirus SV5 small hydrophobic (SH) protein is not essential for virus growth in tissue culture cells. Virology 250, 30-40
56. He B, Lin GY, Durbin JE, Durbin RK, and Lamb RA (2001) The SH integral membrane protein of the paramyxovirus simian virus 5 is required to block apoptosis in MDBK cells. J. Virol. 75, 4068-4079
57. He B, Paterson RG, Stock N, Durbin JE, Durbin RK, Goodbourn S, Randall RE, and Lamb RA (2002) Recovery of paramyxovirus simian virus 5 with a V protein lacking the conserved cysteine-rich domain: the multifunctional V protein blacks both interferon-β induction and interferon signaling. Virology. 303, 15-32
58. Hermodsson S (1963) Inhibition of interferon by an infection with parainfluenza virus type 3 (PIV-3) Virology 20, 333-343
59. Heylbroeck C, Balachandran S, Servant MJ, Deluca G, Barber GN, Lin R, and Hiscott J (2000) IRF-3 transcription factor mediates Sendai virus induced apoptosis. J. Virol. 74, 3781-3792
60. Hiebert SW, Paterson RG, and Lamb RA (1985) Identification and predicted sequence of a previously unrecognized small hydrophobic protein, SH, of the paramyxovirus simian 5. J. Virol. 55, 744-751
61. Hoffman MA, Banerjee AK (1997) An infectious clone of human parainfluenza virus type 3. J. Virol. 71, 4272-4277
62. Horikami SM, Smallwood S, and Moyer SA (1996) The Sendai virus V protein interacts with the NP protein to regulate viral genome RNA replication. Virology 222, 383-390
63. Horikami SM, Hector RE, Smellwood S, and Moyer SA (1997) The Sendai virus C protein binds the L polymerase protein to inhibit vital RNA synthesis. Virology 235, 261-270
64. Huang C, Kiyotani K, Fujii Y, Fukuhara N, Kato A, Nagai Y, Yoshida T, and Sakaguchi T (2000) Involvement of the zinc-binding capacity of Sendai virus V protein in viral pathogenesis. J. Virol. 74, 7834-7841
65. Inoue M, Tokusumi Y, Ban H, Kanaya T, Shirakura M, Tokusumi T, Hirata T, Nagai Y, Iida A, and Hasegawa M (2003) A new type of Sendai virus vector deficient in the matrix gene has lost virus particle formation and gained extensive cell-to-cell spreading. J. Viral. 77, 6419-6429
66. Itoh M, Isegawa Y, Hotta H, and Homma M (1997) Isolation of an avirulent mutant of Sendai virus with two amino acid mutations from a highly virulent field strain through adaptation to LLC-MK2 cells. J. Gen. Virol. 78, 3207-3215
67. Itoh M, Hotta H, and Homma M (1998) Increased induction of apoptosis by a Sendai virus mutant is associated with attenuation of mouse pathogenicity. J. Virol. 72, 2977-2934
68. Jin H, Clarke D, Zhou HZ, Cheng X, Coelingh K, Bryant M, Li S (1998) Recombinant human respiratory syncytial virus (RSV) from cDNA and construction of sub-group A and B chimeric RSV. Virology 251, 206-214
69. Jin H, Cheng X, Zhou HZ, Li S, and Seddiqui A (2000a) Respiratory syncytial virus that lacks open reading frame 2 of the M2 gene (M2-2) has altered growth characteristics, and is attenuated in rodents. J. Virol. 74, 74-82
70. Jin H, Zhou H, Cheng X, Tang R, Munoz M, and Nguyen N (2000b) Recombinant respiratory syncytial virus with deletions in the NS1, NS2, SH, and M2-2 genes are attenuated in vitro and in vivo. Virology 273, 210-218
71. Kai C, Ochikubo F, Okita M, Linuma T, Mikami T, Kobune F, and Yamanouchi K (1993) Use of B95a cells for isolation of canine distemper virus form clinical cases. J. Vet. Med. Sci. 55, 1067-1070
72. Kato A, Sakai Y, Shioda T, Kondo T, Nakanishi M, and Nagai Y (1996) Initiation of Sendai virus multiplication from transfected cDNA or RNA with negative or positive sense. Genes Cells 1, 569-579
73. Kato A, Kiyotani K, Sakai Y, Yoshida T, and Nagai Y (1997a) The paramyxovirus, Sendai virus, V protein encodes a luxury function required for viral pathogenesis. EMBO J. 16, 578-587
74. Kato A, Kiyotani K, Sakai Y, Yoshida T, Shioda T, and Nagai Y (1997b) Importance of the cysteine-rich carboxyl-terminal half of V protein for Sendai virus pathogenesis. J. Virol. 71, 7266-7272
75. Kato A, Kiyotani K, Hasan MK, Shioda T, Sakai Y, Yoshida T, and Nagai Y (1999) Sendai virus gene start signals are not equivalent in reinitiation capacity: Moderation at the F gene. J. Virol. 73, 9237-9246
76. Kato A, Ohnishi Y, Kohase M, Saito S, Tasgiro M, and Nagai Y (2001) Y2, the smallest of Sendai virus C proteins is fully capable of counteracting the anti-viral action of interferons and inhibiting viral RNA synthesis. J. Virol. 75, 3802-3810
77. Kato A, Ohnishi Y, Hishiyama M, Saito S, Tashiro M. and Nagai Y (2002) The amino-terminal half of Sendai virus C protein is not responsible for either counteracting the antiviral action of interferons or down-regulating viral RNA synthesis. J. Virol. 76, 7114-7124
78. Kawano M, Kaito M, Kozuka Y, Komada H, Noda N, Nanba K, Tsurudome M, Ito M, Nishio M, and Ito Y (2001) Recovery of infectious human parainfluenza type 2 virus from cDNA clones and properties of the defective virus without V-specific cysteine-rich domain. Virology 284, 99-112
79. Kiyotani K, Sakaguchi T, Fujii Y, and Yoshida T (2001) Attenuation of a field Sendai virus isolate through egg-passages is associated with an impediment of viral genome replication in mouse respiratory cells. Arch. Virol 146, 893-908
80. Kobune F, Sakata H, and Sugiura A (1990) Marmoset lymphoblastoid cells as a sensitive host for isolation of measles virus. J. Virol. 64, 700-705
81. Kobune F, Sakata H, Sugiyama M, and Sugiura A (1991) B95a, a marmoset lymphoblastoid cell line, as a sensitive host for rinderpest virus. J. Gen. Virol. 72, 687-692
82. Komatsu T, Takeuchi K, Yokoo J, and Gotoh B (2002) Sendai virus C protein impairs both phosphorylation and dephosphorylation processes of Stat1. FEBS Lett. 511, 139-144
83. Komatsu T, Takeuchi K, Yokoo J, Tanaka Y, and Gotoh B (2000) Sendai virus blocks alpha interferon signaling to signal transducers and activators of transcription. J. Virol. 74, 2477-2480
84. Koyama AH, Ogawa M, Kato A, Nagai Y. and Adachi A (2001) Lack of apoptosis in Sendai virus-infected Hep-2 cells without participation of viral antiapoptosis gene. Microbes Infect. 3, 1115-1121
85. Koyama AH, Irie H, Kato A, Nagai Y, and Adachi A (2003) Virus multiplication and induction of apoptosis by Sendai virus: role of the C proteins. Microbes Infect. 5, 373-378
86. Kubota T, Yokosawa N, Yokota S. and Fujii N (2001) C terminal Cys-rich region of mumps virus structural V protein correlates with block of interferon alpha and gamma signal transduction through decrease of STAT1-alpha. Biochem Biophys Res Commun 283, 255-259
87. Kubota T, Yokosawa N, Yokota S. and Fujii N (2002) Association of mumps virus V protein with RACK1 results in dissociation of STAT1 from the alpha interferon receptor complex. J. Virol. 16, 12676-12682
88. Kurotani A, Kiyotani K, Kato A, Shioda T, Sakai Y, Mizumoto K, Yoshida T, and Nagai Y (1998) Sendai virus C proteins are categorically nonessential gene products but silencing their expression severely impairs viral replication and pathogenesis. Genes Cells 3, 111-124
89. Lamb RA, and Choppin PW (1977) The synthesis of Sendai virus polypeptides in infected cells. III. Phosphorylation of polypeptides. Virology 81, 382-397
90. Lamb RA, and Kolakofsky D (2001) Paramyxoviridae: The viruses and their replication, pp. 1305-1340. In Fields Virology 4th ed. Lippincott Williams & Wilkins, Philadelphia
91. Latorre P, Cadd T, Itoh M, Curran J, and Kolakofsky D (1998) The various Sendai virus C proteins are not functionally equivalent, and exert both positive and negative effects on viral RNA accumulation during the course of infection. J. Virol. 72, 5984-5993
92. Li H-O, Zhu YF, Asakawa M, Kuma H, Hirata T, Ueda Y, Lee YS, Fukumura M, Iida A, Kato A, Nagai Y, and Hasegawa M (2000) A cytoplasmic RNA vector from non-transmissible Sendai virus with efficient gene transfer and expression. J. Virol 74, 6564-6569
93. Lin GY, Paterson RG, Richardson CD, and Lamb RA (1998a) The V protein of the paramyxovirus SV5 interacts with damage-specific DNA binding protein. Virology 249, 189-200
94. Lin R, Heylbroeck C, Pitha PM, and Hiscott J (1998b) Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear transport, transcription potential, and proteasome-mediated degradation. Mol. Cell. Biol. 18, 2986-2996
95. Lin GY, and Lamb RA (2000) The paramyxovirus simian virus 5 V protein slows progression of the cell cycle. J. Virol. 74, 9155-9166
96. Lin Y, Bright AC, Rothermel TA, and He B (2003) Induction of apoptosis by paramyxovirus simian virus 5 lacking a small hydrophobic gene. J. Virol. 77, 3371-3383
97. Liston P, and Briedis DJ (1994) Measles virus V protein binds zinc. Virology 198, 399-404
98. Liston P, and Briedis DJ (1995) Ribosomal frameshifting during translation of measles virus P protein mRNA is capable of directing synthesis of a unique protein. J. Virol. 69, 6742-6750
99. Maeno K, Yoshii S, Nagata I, and Mastumoto T (1966) Growth of Newcastle disease virus in a HVJ carrier culture of HeLa cells. Virology 29, 255-263
100. Matsumoto T (1982) Assembly of paramyxoviruses. Microbiol. Immunol. 26, 285-320
101. Mebatsion T, Verstegen S, De Vaan LT, Romer-Oberdorfer A, and Schrier CC (2001) A recombinant Newcastle disease virus with low-level V protein expression is immunogenic and lacks pathogenicity for chicken embryos. J. Virol. 75, 420-428
102. Mochly-Rosen D, Khaner H, and Lopez J (1991) Identification of intracellular receptor proteins for activated protein kinase C. Proc. Natl. Acad. Sci. USA 88, 3997-4000
103. Nagai Y (1993) Protease-dependent virus tropism and pathogenicity. Trends Microbiol 1, 81-87
104. Nagai Y (1999) Paramyxovirus replication and pathogenesis. Reverse genetics transforms understanding. Rev. Med. Virol. 9, 83-99
105. Nagai Y, Yoshida T, Yoshii S, Maeno K, and Matsumoto T (1975) Modification of normal cell surface by smooth membrane preparations from BHK-21 cells infected with Newcastle disease virus. Med. Microbiol. Immunol. 161, 175-188
106. Nagai Y, Klenk HD, and Rott R (1976a) Proteolytic cleavage of the viral glycoproteins and its significance for the virulence of Newcastle disease virus. Virology 72, 494-508
107. Nagai Y, Ogura H, and Klenk HD (1976b) Studies on the assembly of the envelope of Newcastle disease virus. Virology 69, 523-538
108. Nagai Y, and Kato A (1999) Paramyxovirus reverse genetics is coming of age. Microbial Immunol 43, 613-624
109. Nishikawa F (1997) On HIJ. Virus 47, 261-265 (in Japanese)
110. Nishio M, Tsurudome M, Ito M, Kawano M, Komada H, and Ito Y (2001) High resistance of human parainfluenza type2 virus protein-expressing cells to the antiviral and anti-cell proliferative activities of α/β interferons: cysteine-rich v- specific domain is required for high resistance to the interferons. J. Virol. 75, 9165-9176
111. Parisien JP, Lau JF, Rodriguez JJ, Sullivan BM, Moscona A, Parks G.D, Lamb RA, and Horvath CM (2001) The V protein of human parainfluenza virus 2 antagonizes type I interferon responses by destabilizing signal transducer and activator of transcription 2. Virology 283, 230-239
112. Parisien JP, Lau JF, Horvath CM (2002a) STAT2 acts as a host range determinant for species-specific paramyxovirus interferon antagonism and simian virus 5 replication. J. Virol. 76, 6435-6441
113. Parisien JP, Lau JF, Rodriguez JJ, Ulane CM, and Horvath CM (2002b) Selective STAT protein degradation induced by paramyxoviruses requires both STAT1 and STAT2 but is independent of α/β interferon signal transduction. J. Virol. 76, 4190-4198
114. Park MS, Shaw ML, Munoz-Jordan J, Cros JF, Nakaya T, Bouvier N, Palese P, Garcia-Sastre A, and Basler CF (2003) Newcastle disease virus (NDV)-based assay demonstrates interferon-antagonist activity for the NDV V protein and the Nipah virus V, W, and C proteins. J. Virol. 77, 1501-1511
115. Paterson R, Leser G, Shaughnessy M, and Lamb R (1995) The paramyxovirus SV5 V protein binds two atoms of zinc and is a structural component of virions. Virology 208, 121-131
116. Patterson JB, Thomas D, Lewicki H, Billeter MA, and Oldstone MB (2000) V and C proteins of measles virus function as virulence factors in vivo. Virology 267, 80-89
117. Peeters BPH, DE Leeuw OS, Koch G, and Gielkens ALJ (1999) Rescue of Newcastle disease virus from cloned cDNA: evidence that cleavability of the fusion protein is a major determinant for virulence. J. Virol. 73, 5001-5009
118. Pelet T, Curran J, and Kolakofsky D (1991) The P gene of bovine parainfluenza virus 3 expresses all three reading frames from a single mRNA editing site. EMBO J. 10, 443-448
119. Pikart CM (2001) Mechanisms underlying ubiquitination. Annu. Rev. Biochem. 70, 503-533
120. Poole E, He B, Lamb RA, Randal RE, and Goodbourn S (2002) The V proteins of simian virus 5 and other paramyxoviruses inhibit induction of interferon-β. Virology. 303, 33-46
121. Power UF, Ryan KW, and Portner A (1992) The P genes of human parainfluenza virus type 1 clinical isolates are polycistronic and microheterogeneous. Virology 189, 340-343
122. Radecke F, and Billeter MA (1996) The nonstructural C protein is not essential for multiplication of Edmonston B strain measles virus in cultured cells. Virology 217, 418-421
123. Rodriguez JJ, Parisien JP, and Horvath CM (2002) Nipah virus V protein evades alpha and gamma interferons by preventing STAT1 and STAT2 activation and nuclear accumulation. J. Virol. 76, 11476-11483
124. Ron D, Chen C-H, Caldwell J, Jamieson L, Orr E, and Mochly-Rosen D (1994) Cloning of an intracellular receptor for protein kinase C: a homolog of the beta subunit of G protein. Proc. Natl. Acad. Sci. USA 91, 839-843
125. Rose KJ, and Whitt MA (2001) Rhabdoviridae: the viruses and their replication. pp. 1221-1244. In Fields Virology 4th ed. Lippincott Williams & Wilkins, Philadelphia
126. Saito S, Ogino T, Miyajima N, Kato A, and Kohase M (2002) Dephosphorylation failure of tyrosine-phosphorylated STAT1 in IFN-stimulated Sendai virus C protein-expressing cells. Virology 293, 205-209
127. Sakaguchi T, Kiyotani K, Kato A, Asakawa M, Fujii Y, Nagai Y, and Yoshida T (1997) Phosphorylation of the Sendai virus M protein is not essential for virus replication either in vitro or in vivo. Virology 235, 360-366
128. Sakaguchi T, Kiyotani K, Watanabe H, Huang C, Fukuhara N, Fujii Y, Shimazu Y, Sugahara F, Nagai Y, and Yoshida T (2003) Masking of the contribution of V protein to Sendai virus pathogenesis in an infection model with a highly virulent field isolate. Virology 313, 581-587
129. Sakaguchi T, Uchiyama T, Huang C, Fukuhara N, Kiyotani K, Nagai Y, and Yoshida T (2002) Alteration of Sendai virus morphogenesis and nucleocapsid incorporation due to mutation of cysteine residues of the matrix protein. J. Virol. 76, 1682-1690
130. Schneider H, Kaelin K, and Billeter MA (1997) Recombinant measles viruses defective for RNA editing and V protein synthesis are viable in cultured cells. Virology 227, 314-322
131. Schlender J, Bossert B, Buchholz U, and Conzelmann KK (2000) Bovine respiratory syncytial virus nonstructural proteins NS1 and NS2 cooperatively antagonize alpha/beta interferon-induced antiviral response. J. Virol. 74 8234-8242
132. Takeda M, Kato A, Kobune F, Sakata H, Li Y, Shioda T, Sakai Y, Asakawa M, and Nagai Y (1998) Measles virus attenuation associated with transcriptional impediment and a few amino acid changes in the polymerase and accessory proteins. J. Virol. 72, 8690-8696
133. Takeda M, Kato A, Sakaguchi T, Kobune F, Li Y, and Nagai Y (1999) The genome nucleotide sequence of a contemporary wild-strain of measles virus and its comparison with the classical Edmonston strain genome. Virology 256, 340-350
134. Takeda M, Takeuchi K, Miyajima N, Kobune F, Ami Y, Nagata N, Suzuki Y, Nagai Y, and Tashiro M (2000) Recovery of pathogenic measles virus from cloned cDNA. J. Virol. 74, 6643-6647
135. Takeuchi K, Tanabayashi K, Hishiyama M, et al (1991) Variation of nucleotide sequences and transcription of the SH gene among mumps virus strains. Virology 181, 364-366
136. Takeuchi K, Komatsu T, Yokoo J, Kato A, Shioda T, Nagai Y, and Gotoh B (2001) Sendai virus C protein physically associates with Stat1. Genes Cells 6, 545-557
137. Talon J, Horvath CM, Polley R, Basler CF, Muster T, Palese P, and Garcia-Sastre A (2000) Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J. Virol. 74, 7989-7996
138. Tanaka N, Sato M, Lamphier MS, Nozawa H, Oda E, Noguchi S, Schreiber RD, Tsujimoto Y, and Taniguchi T (1998) Type 1 interferons are essential mediators of apoptotic death in virally infected cells. Genes Cells 3, 29-37
139. Taniguchi T, Ogasawara K, Takaoka A, and Tanaka N (2001) IRF family of transcription factors as regulators of host defense. Annu. Rev. Immunol. 19, 623-655
140. Tapparel C, Hausmann S, Pelet T, Curran J, Kolakofsky D, and Roux L (1997) Inhibition of Sendai virus genome replication due to promoter-increased electivity: a possible role for the accessory C proteins. J. Virol. 71, 9588-9599
141. Tatsuo H, Ono N, Tanaka K, and Yanagi Y (2000) SLAM(CDw150) is a cellular receptor for measles virus. Nature 406, 893-897
142. Teng MN, and Collins PL (1999) Altered growth characteristics of recombinant respiratory syncytial viruses, which do not produce NS2 protein. J. Virol. 73, 466-473
143. Thomas SM, Lamb RA, and Paterson RG (1988) Two mRNAs that differ by two non-templated nucleotides encode the amino coterminal proteins P and V of the paramyxovirus SV5. Cell 54, 891-902
144. Tidona CA, Kurz HW, Gelderblom HR, and Darai G (1999) Isolation and molecular characterization of a novel cytopathogenic paramyxovirus from tree shrews. Virology 258, 425-434
145. Tober C, Seufert M, Schneider H, Billeter MA, Johnston ICD, Niewiesk S, ter Meulen V, and Schneider-Schaulies S (1998) Expression of measles virus V protein is associated with pathogenicity and control of viral RNA synthesis. J. Virol. 72, 8124-8132
146. Trono D (1995) HIV accessory proteins: Leading roles for the supporting cast. Cell 82, 189-192
147. Ulane CM, and Horvath CM (2002) Paramyxoviruses SV5 and hPIV2 assemble STAT protein ubiquitin ligase complexes from cellular components. Virology 304, 160-166
148. Usacheva A, Smith R, Minshall R, Baida G, Seng S, Croz E, and Colamonici O (2001) The WD motif-containing protein receptor for activated protein kinase C (RACK1) is required for recruitment and activation of signal transducer and activator of transcription 1 through the type i interferon receptor. J. Biol. Chem. 276, 22948-22953
149. Valle M, and Cantell K (1965) The ability of Sendai virus to overcome cellular resistance to vesicular stomatitis, virus I. Ann. Med. Exp. Biol. Fenn. 43, 57-60
150. Valsamakis A, Schneider H, Auwaerter PG., Kaneshima H, Billeter MA, and Griffin DE (1998) Recombinant measles viruses with mutations in the C, V, or F gene have altered growth phenotypes in vivo. J. Virol. 72, 7754-7761
151. Vidal S, Curran J, and Kolakofsky D (1990a) A stuttering model for paramyxovirus P mRNA editing. EMBO J. 9, 2017-2022
152. Vidal S, Curran J, and Kolakofsky D (1990b) Editing of the Sendai virus P/C mRNA by G insertion occurs during mRNA synthesis via a virus-encoded activity. J. Virol. 64, 239-246
153. Wang LF, Michalski WP, Yu M, Pritchard LI, Crameri G, Shiell B, and Eaton BT (1998) A novel PN/C gene in a new member of the Paramyxovirus family, which causes lethal infection in humans, horses, and other animals. J. Virol. 72, 1482-1490
154. Wansley EK, and Parks GD (2002) Naturally occurring substitutions in the P/V gene convert the noncytopathic paramyxovirus simian virus 5 into a virus that induces alpha/beta interferon synthesis and cell death. J. Virol. 76, 10109-10121
155. Whitehead SS, Bukreyev A, Teng MN, Firestone CY, St Claire M, Elkins WR, Collins PL, and Murphy BR (1999) Recombinant respiratory syncytial virus bearing a deletion of either the NS2 or SH gene is attenuated in chimpanzees. J. Virol. 73, 3438-3442
156. Yanagi Y, Ono N, Tatsuo H, Hashimoto K, and Minagawa H (2002) Measles virus receptor SLAM (CD150) Virology 299, 155-161
157. Yokosawa N, Yokota S, Kubota T, and Fujii N (2002) C-terminal region of STAT1α is not necessary for its ubiquitination and degradation caused by mumps virus V protein. J. Virol. 17, 12683-12690
158. Yokota S, Saito H, Kubota T, Yokosawa N, Amano K, and Fujii N (2003) Measles virus suppresses interferon-α signaling pathway: suppression of Jak1 phosphorylation and association of viral accessory proteins, C and V, with interferon-α receptor complex. Virology 305 (in press)
159. Yonemitsu Y, Kiston C, Ferrari S, Farley R, Griesenbach U, Judd D, Steel R, Scheid P, Zhu J, Jeffery PK, Kato A, Hasan MK, Nagai Y, Fukumura M, Hasegawa M, Geddes DM, and Alton EWFW (2000). Efficient gene transfer to airway epithelium using recombinant Sendai virus. Nat. Biotech. 18, 970-974
160. Yoshida T, Nagai Y, Yoshii S, Maeno K, Matsumoto T, and Hoshino M (1976) Membrane (M) protein of HVJ (Sendai virus): its role in virus assembly. Virology 71, 143-161
161. Yoshida T, Nagai Y, Maeno K, Iinuma M, Hamaguchi M, Matsumoto T, Nagayoshi S, and Hoshino M (1979) Studies on the role of M protein in virus assembly using a ts mutant of HVJ (Sendai virus): its role in virus assembly. Virology 71, 143-161
162. Young DF, Didcock L, Goodbourn S, and Randall RE (2000) Paramyxoviridae use distinct virus-specific mechanisms to circumvent the interferon response. Virology 269, 383-390
163. Young DF, Chatziandreou N, He B, Goodbourn S, Lamb RA, and Randall RE
164. Yu D, Shioda T, Kato A, Hasan MK, Sakai Y, and Nagai Y (1997) Sendai virus-based expression of HIV-1 gp120: reinforcement by the V(-) version. Genes Cells 2, 457-466